baber/WOPTO huggingface dataset:
Patent CA-2722079-A1 (CA)
Inventor: MONDEN RYUJI
IPC: B01J32/00
Filed: 2009-02-10
Abstract: Disclosed is a catalyst carrier having excellent durability, which has high catalytic ability without increasing the specific surface area thereof. Also disclosed is a catalyst using the catalyst carrier. Specifically disclosed is a catalyst carrier composed of a metal oxycarbonitride. The metal oxycarbonitride preferably contains at least one metal selected from the group consisting of niobium, tin, indium, platinum, tantalum, zirconium, copper, iron, tungsten, chromium, molybdenum, hafnium, titanium, vanadium, cobalt, manganese, cerium, mercury, plutonium, gold, silver, iridium, palladium, yttrium, ruthenium, lanthanum, cerium, praseodymium, neodymium, promethium, samarium, europium, gadolinium, terbium, dysprosium, holmium, erbium, thulium, ytterbium, lutetium and nickel. Also specifically disclosed is a catalyst which is composed of the catalyst carrier and a catalyst metal supported by the catalyst carrier.
Patent CA-2722294-A1 (CA)
Title: Method and system for cryoablation treatment
Inventor: BABKIN ALEXEI V
IPC: A61B18/02
Filed: 2009-04-21
Abstract: A system and a method for its use are provided to cool a cryotip at the distal end of a probe for a cryosurgical procedure. In particular, the cryotip is cooled by a liquid refrigerant to cryogenic temperatures in order to perform a cryosurgical procedure on biological tissue. The system is closed-loop, and during transit of the liquid refrigerant through the entire system, the liquid refrigerant always remains in a liquid state at a relatively low pressure.
Patent CA-2725626-A1 (CA)
Inventor: ROUX MICHEL
IPC: G01N23/04
Filed: 2008-11-17
Abstract: A tray is provided for supporting bottles filled with liquid while the bottles filled with liquid are subjected to an X-ray inspection at a security checkpoint to determine the threat status of the bottles filled with liquid. Each bottle filled with liquid is characterized by a transverse dimension and a longitudinal dimension and is of an overall size suitable to be carried in hand-carried luggage allowed onboard a commercial aircraft. The tray includes a plurality of elongated recesses for receiving bottles filled with liquid, the recesses being defined between opposing walls spaced to engage the bottles filled with liquid on its sides when the bottles filled with liquid are placed in the recesses, the opposing walls preventing the bottles filled with liquid from rocking in the recesses during the X-ray inspection. In different embodiments, the recess may be arranged to hold a bottle filled with liquid in a position such that a meniscus in the bottle filled with liquid has a tendency to migrate toward an extremity of the bottle filled with liquid. A  method for assessing the threat status of a bottle filled with liquid at a security checkpoint is also provided.
Patent CA-2726132-A1 (CA)
Inventor: BEISSEL JOCHEM
IPC: B21D5/10
Filed: 2009-05-28
Abstract: The invention relates to a method for pro-ducing a steel tube, wherein a steel sheet (4) is formed into tubular body (1.2) having a round cross section in a ben-ding process (a), welded in a subsequent welding process (b) along the longitudinal edges facing each other for pro-ducing a continuous longitudinal seam, and then subjected to a stress-relieving treatment. The production quality is improved, with reduced production time, in that the stress--relieving treatment is performed in a process (c) for con-centrically truing along the circumference in at least one segment relative to the longitudinal axis thereof, while cold forming by compression (Fig. 1). The mechanical technological properties of the material are also thereby improved.
Patent CA-2726522-A1 (CA)
Inventor: LI YIWEN
IPC: C12N5/10
Filed: 2009-05-28
Abstract: The present invention provides fully human antibodies that specifically bind to human FLT3 within extracellular domains 4 or 5 with high affinity. The invention further provides methods of treating leukemia by administering an effective amount of an antibody either alone or in combination with an anti-cancer agent or treatment including methotrexate.
Patent CA-2727689-A1 (CA)
Title: Converter device and method for converting electrical power
Inventor: ANDRESEN BJOERN
IPC: H02M5/04
Filed: 2011-01-12
Abstract: It is described a converter device (102) for power conversion in e.g. a power plant such as a wind turbine. An individual controller (116a, 116b, 116c) is provided for each phase (110a, 110b, 110c) of an electrical output power (108) of the converter. If a voltage of one phase is indicated as being out of a predetermined voltage band, an active current of this phase is set to zero and optionally a reactive component of this phase is set to a value that depends on the indicated voltage.
Patent CA-2727808-A1 (CA)
Inventor: COLLIER NICHOLAS JOHN
IPC: A61B17/94
Filed: 2011-01-12
Abstract: A surgical retrieval apparatus includes an elongate flexible tubular member having a distal opening and a lumen and a support member having a chamber formed therein in fluid communication with the tubular member and movable from a first position to a second expanded position in response to introduction of fluid into the chamber. A retrieval bag extends from the support member and has a first end and a closed second end. The first end of the retrieval bag is movable to an open configuration when the expandable member transitions from the first position to the second expanded position.
Patent CA-2731403-A1 (CA)
Inventor: KNUST HENNER
IPC: A61P25/00
Filed: 2009-07-20
Abstract: The present invention is concerned with compounds of formula (I) wherein R1, R2, Ar, Hetaryl, m and n are as de-scribed in the description and claims. The compounds are orexin receptor antagonists may be useful in the treatment of disorders, in which orexin pathways are involved.
Patent CA-2736295-A1 (CA)
Inventor: BURDACK CHRISTOPH
IPC: A61P31/00
Filed: 2009-09-15
Abstract: The present invention provides compounds of formula (I) or (Ia) which are ligands binding to the HDM2 protein, inducing apoptosis and inhibiting proliferation, and having therapeutic utility in cancer therapy and prevention. Compounds of formula (I) or (Ia) can be used as therapeutics for treating stroke, myocardial infarction, ischemia, multi-organ failure, spinal cord injury, Alzheimer's Disease, injury from ischemic events and heart valvular degenerative disease. Moreover, compounds of formu-la (I) or (Ia) can be used to decrease the side effects from cytotoxic cancer agents, radiation and to treat viral infections.
Patent CA-2737873-A1 (CA)
Inventor: PULFORD KAREN
IPC: C07K14/47
Filed: 2009-10-01
Abstract: The present invention relates to immunogenic peptides and their various applications. In particular the invention relates to immunogenic peptides derived from the PASD1 protein and their use in therapeutic, diagnostic and prognostic methods.
Patent CA-2739326-A1 (CA)
Inventor: DRASLER WILLIAM
IPC: A61M29/02
Filed: 2009-10-09
Abstract: A valvuloplasty catheter has a dog-bone shaped balloon with semi-compliant smaller diameter waist and non-compliant larger diameter bulbous end regions. The balloon centers across the valve with the waist adjacent to the annulus. One bulbous region serves to hyperextend the valve leaflets and the other assists in stabilizing the balloon position to reduce migration.    The semi-compliant waist increases in diameter as fluid enters the balloon until it comes into contact with the valve annulus. The pressure within the balloon per unit of volume delivery has a greater slope after contact with the annulus than before resulting in a change in slope for the pressure versus volume curve. The diameter of the balloon and annulus are determined at this inflection point when the balloon contacts the annulus.
Patent CA-2739787-A1 (CA)
Inventor: VASQUEZ MIGUEL ANGEL DUARTE
IPC: A61K31/662
Filed: 2009-10-08
Abstract: The present invention provides .beta.-hydroxy-.gamma.-aminophosphonates, .beta.-amino-.gamma.- aminophosphonates, and analogs thereof that inhibit carnitine acyltransferases. The invention also provides compositions comprising these .beta.-hydroxy-.gamma.-aminophos-phonates, .beta.-amino-.gamma.- aminophosphonates, and analogs, and methods of the use of such compounds and compositions in the treat-ment, amelioration or prevention of pathological conditions, diseases or disorders that are linked with fatty acid metabolism, such as non-insulin dependent diabetes or obesity. The invention also provides processes for the preparation of such compounds and compositions.
Patent CA-2740417-A1 (CA)
Inventor: WONG BRENDA L
IPC: C12Q1/68
Filed: 2009-10-15
Abstract: Gene expression in peripheral blood from individuals with Duchenne muscular dystrophy (DMD), compared to control individuals, demonstrated differential gene sets that could be used in a method to diagnose DMD, to evaluate effect of DMD therapy, and/or to evaluate propensity to DMD.
Patent CA-2741875-A1 (CA)
Inventor: STULL RANDY LELAND
IPC: C03C17/00
Filed: 2009-11-03
Abstract: A substrate having a coating is disclosed. The coating is formed of a plurality of layers. At least one of the layers includes a Nickel -Chromium-Molybdenum alloy and at least two additional layers including silver. A coating for a substrate is also disclosed. A  method of applying a coating to a substrate is further disclosed.
Patent CA-2742619-A1 (CA)
Inventor: BARRETT LOUIS L
IPC: G16H10/60
Filed: 2009-09-23
Abstract: A hemodialysis patient data acquisition and management system resides on a host computer (90) which receives information from one or more non-invasive, optical blood monitors (14) associated with a hemodialysis system (12). When a patient (10) is undergoing hemodialysis treatment, a sensor assembly (34) monitors the patient's blood flowing through the hemodialysis system and a controller (35) for the blood monitor generates data which includes at least an identification code for the patient undergoing the treatment on the respective system, and non-invasively determined blood data taken at the onset of the scheduled treatment, such as initial Hgb, HCT, and SAT values. A host computer communicates with the one or more optical blood monitors, preferably via a wireless network, and the patient's session commencement data is downloaded to the host computer. The host computer includes a patient database (93), as well as screen displays (102) for displaying historical date for individual patients, such as Hgb trends.
Patent CA-2745565-A1 (CA)
Inventor: HORVATH ANDRAS
IPC: C07D311/06
Filed: 2009-12-22
Abstract: The present invention relates to the cinchonidine salt useful in the preparation of intermediates for preparing a macrocyclic HCV inhibitor, as well as processes involving this salt.
Patent CA-2745607-A1 (CA)
Title: Torso and head secured spinal immobilisation apparatus
Inventor: COOKE MATTHEW WILLIAM
IPC: A61F5/058
Filed: 2009-12-16
Abstract: A spinal immobilisation apparatus has a harness for immovably securing to the torso of a person and a separate head support of collarless construction for mounting about the head of a person. Releasable connection allows the head support to be adjustably secured on the harness in relation to the shoulders and back of the wearer. The harness configuration allows ready access to the wearer's chest area. Elastication allows the cheat to expand during breathing. The head support is of open-faced, open-topped structure having rigid side walls hingedly connected to a rigid rear wall.
Patent CA-2746796-A1 (CA)
Title: Method for speeding up plant growth and improving yield by introducing phosphatases in transgenic plant
Inventor: LIM BOONLEONG
IPC: A01H5/00
Filed: 2009-12-16
Abstract: Transgenic plants having increased growth rate, increased sugar content, and increase yield are disclosed, and methods for making the same. The transgenic plants have a gene coding for a phosphatase having a C-terminal motif under control of a heterologous promoter incorporated into the genomic DNA of the plant.
Patent CA-2747939-A1 (CA)
Title: A composition comprising a retinoid and method of treating skin conditions
Inventor: ODDOS THIERRY
IPC: A61K31/07
Filed: 2009-12-22
Abstract: This invention relates to compositions containing a retinoid and use of the compositions for treating skin condi-tions.
Patent CA-2748518-A1 (CA)
Inventor: LEE SANG-SUN
IPC: A62C3/07
Filed: 2009-12-24
Abstract: The present invention relates to a sprinkler with an integrated valve, and to a fire-extinguishing system using same. Conventional sprinklers are too sensitive to the outbreak of a fire, and operate even if no fire has broken out, which would lead to a large amount of damage. For this reason, conventional sprinklers are often prevented from being operated in advance. In addition, sprinklers do not operate even upon the outbreak of a fire when the sensitivities thereof are lowered, rendering the sprinklers useless.  The present invention aims to solve the abovementioned problems, and is configured such that a manager in a building checks whether or not a fire has broken out and if so sends an extinguishing signal, and wherein in the event a sensor for operating a sprinkler senses the outbreak of a fire, only the relevant sprinkler operates by means of a valve mounted thereon, thereby operating sprinklers only when a fire has actually broken out, and enabling a central control office, a fire station, or the like to verify the outbreak of a fire in each household at all times. Further the present invention can be applied to public transportation facilities such that water-spraying is carried out after an engine room or a control board in charge of the safety of the passenger cars and outside of the latter verifies the outbreak of a fire, thus still taking advantage of a high-sensitivity of sensor. As the present invention sprinklers water only in the event of an actual fire outbreak, erroneous operation can be prevented, and water can be sprinkled only in the required area, thereby extinguishing the fire in the early state of a fire outbreak.
Patent CA-2753568-A1 (CA)
Inventor: VAN DER STOK PETRUS D V
IPC: H05B37/02
Filed: 2010-02-19
Abstract: The invention relates to automatically commissioning of devices of a networked control system, particularly to automatically commissioning (auto-commissioning) of light sources of a lighting system, where a control of light sources on an individual and local basis is required. A basic idea of the invention is to route commissioning messages through a grid, particularly an approximately rectangular grid of devices in that each device is able to receive commissioning messages from and to transmit commissioning messages to directly neighbored devices in the grid via light. An embodiment of the invention relates to a method for automatically commissioning of devices (10, 12, 14, 16, 18) of a networked control system, which comprises several devices arranged in a grid (20), wherein each device is adapted for routing messages, which were received from directly neighbored devices in the grid, to directly neighbored devices in the grid via light, wherein the commissioning comprises the acts of - transmitting a commissioning message (S1O), which comprises a hops counter, by a first device (10) to a second device (12), which is neighbored to the first device in a predetermined direction (22) in the grid, - receiving the commissioning message (S 12) from the first device by the second device, -updating the hops counter (S 14) by the second device and a location counter of the second device and - transmitting the commissioning message (S 16) with the updated hops counter to one or more third devices.
Patent CA-2755132-A1 (CA)
Inventor: SHIMIZU KAZUO
IPC: A61P19/02
Filed: 2010-03-30
Abstract: The present invention provides compounds useful as agents for the prevention or treatment of a disease associated with abnormal serum uric acid level and the like.  That is, the present invention relates to indolizine derivatives represented by the following formula (I) having xanthine oxidase inhibitory activities and useful as agents for the prevention or treatment of a disease associated with abnormality of serum uric acid level, prodrugs thereof, salts thereof or the like. In the formula, ring U represents aryl or heteroaryl; R1 represents halogen, a hydroxy group or the like; R2 represents halogen, a hydroxy group, alkyl, alkoxy, alkyl substituted by fluorine, alkoxy substituted by fluorine or the like; m represents a number from 0 to 2; n represents a number from 0 to 3; and R3 represents hydrogen, fluorine or the like.   (see formula I)
Patent CA-2757227-A1 (CA)
Title: Use of a magnetic resonance imaging medium comprising hyperpolarized 13c pyruvate for the detection of inflammation or infection
Inventor: YEN YI-FEN
IPC: G01R33/28
Filed: 2010-03-25
Abstract: The invention relates to a method of 13C-MR imaging, 13C-MR spectroscopy and/or 13C-MR spectroscopic imaging of inflammation or infection using an imaging medium which comprises a hyperpolarized 13C-substance.
Patent CA-2758466-A1 (CA)
Inventor: BURNS DONALD
IPC: F02C6/20
Filed: 2011-11-16
Abstract: One embodiment of the present invention is a unique aircraft. Another embodiment is a unique aircraft propulsion system. Still another embodiment is a unique system for taxiing an aircraft without starting one or more main aircraft propulsion engines. Other embodiments include apparatuses, systems, devices, hardware, methods, and combinations for aircraft taxiing and propulsion systems.  Further embodiments, forms, features, aspects, benefits, and advantages of the present application will become apparent from the description and figures provided herewith.
Patent CA-2760732-A1 (CA)
Inventor: VORBERG GERALD
IPC: B01D53/14
Filed: 2010-05-12
Abstract: An absorbent for removing acid gases from a fluid flow comprises an aqueous solution of a) at least one amine and b) at least one phosphonic acid, wherein the molar ratio of b) to a) ranges between 0.0005 and 1Ø For example, the phosphonic acid is 1-hydroxyethane-1, 1-diphosphonic acid.  Compared to absorbents based on amines or amine/promoter combinations, the absorbent requires less regeneration energy without substantially reducing the solution's capacity to absorb acid gases.
Patent CA-2761033-A1 (CA)
Inventor: SEMLER JOHN R
IPC: A61B5/02
Filed: 2010-03-30
Abstract: A method of determining body exit of an ingestible capsule comprising the steps of providing (40) an ingestible capsule (20) having a pressure sensor (23), having (41) a subject ingest the capsule, recording (42a) measurements from the pressure sensor as the capsule passes through at least an end portion of a gastrointestinal tract of the subject, transmitting (44) the measurements to a processor (31) outside of the gastrointestinal tract of the subject, identifying (47) an increasing pressure sequence (65) in the measurements between a selected start time (62) and a transmission end time (63), comparing (48) the sequence to a reference (66), and using the comparison to make a determination (52) regarding the capsule exiting the gastrointestinal tract of the subject. The increasing pressure sequence may be the longest increasing pressure sequence in the measurements. The reference may be a logarithmic regression of the measurements.    The ingestible capsule may further comprise a temperature sensor (22) and the method may further comprising the steps of recording (42b) measurements from the temperature sensor as the capsule passes through the end portion of the gastrointestinal tract of the subject, transmitting (43) the measurements to the processor, analyzing (46) the temperature measurements for a substantial drop (68) in the temperature measurements, and using the analysis of the temperature measurements to make the determination regarding the capsule exiting the gastrointestinal tract of the subject.
Patent CA-2761929-A1 (CA)
Inventor: CICCONE DENNIS M
IPC: B64C13/50
Filed: 2011-12-13
Abstract: An electric brake power conversion and distribution system for use in aircraft is provided. An array of DC-DC converters is interposed between a DC power source and a plurality of aircraft electric brake actuators. Each of the DC-DC converters has a characteristic output voltage. The DC-DC converters are interconnected in an additive series of connections to provide an output voltage to the plurality of aircraft electric brake actuators that comprises the sum of the characteristic voltages of the DC-DC converters that are enabled at a particular point in time. A controller manipulates an array of switches interconnected with the array of DC-DC converts, such that the controller can selectively enable or inhibit selected ones of the DC-DC converters, as desired. Accordingly different voltages can be made available for the electric brake actuators depending upon aircraft activity, such as landing, taxiing, parking, or in flight. The invention reduces the size, weight, cost, and associated heat buildup of prior power conversion and distribution systems.
Patent CA-2764812-A1 (CA)
Title: Systems and apparatus for automatically deriving and modifying personal preferences applicable to multiple controllable lighting networks
Inventor: LOVELAND DAMIEN
IPC: H04L12/28
Filed: 2010-05-18
Abstract: Systems and methods for deriving and modifying personal preferences related to at least one controllable lighting network are disclosed. The systems include a processor that can be used in conjunction with a personal communication device and a preferences database. The processor is used to detect an identifier for a user, a plurality of adjustments to the at least one controllable lighting network requested by the user, and a context corresponding to each of the plurality of adjustments. The processor in some such systems has an associated local memory to store the plurality of adjustments, corresponding contexts, and the identifier of the associated user. The processor is further used to analyze the plurality of lighting adjustments and the corresponding contexts.  Based on the analysis, the processor identifies a correlation between the plurality of adjustments and the contexts, and create at least one personal preference rule associated with the user identifier based on the correlation. The preferences database in some such systems is used to store the rules and the plurality of adjustments.
Patent CA-2765737-A1 (CA)
Inventor: MORAZZONI PAOLO
IPC: C07K14/415
Filed: 2010-06-16
Abstract: A truncated form of a' chain (ea'), the soybean 7S globulin, active in controlling the cholesterol and triglyceride homeostasis in in vitro and in vivo models, was cloned and expressed in the yeast Pichia pastoris. The recombinant polypeptide spanned 142 amino acid residues from the N-terminal side and included the N-terminal extension region of the soybean alpha' subunit. The ea' polypeptide was purified by conventional biochemical techniques and its potential to modulate the activity of the LDL-receptor was evaluated in a human hepatoma cell line (Hep G2) by monitoring the uptake and degradation of labeled LDL.
Patent CA-2767441-A1 (CA)
Title: Gravity base structure
Inventor: FOOTE BERNARD
IPC: B63B35/44
Filed: 2012-02-07
Abstract: Embodiments of gravity base structures are disclosed that comprise first and second elongated base sections separated by an open region and configured to support the on-bottom weight of the structure and be supported by the floor of the body of water, and an upper section positioned above the open region and configured to extend at least partially above the water surface to support topside structures. Some embodiments further comprise first and second inclined sections coupling the base sections to the upper section.